AN2 Therapeutics, Inc.ANTXNASDAQ
LOADING
|||
EPS Growth Under Pressure
Trending lower, below historical average.
Left:
||||
Year-over-year earnings per share growth rate
Latest
-47.62%
↓ 466% below average
Average (18q)
-8.42%
Historical baseline
Range
High:41.86%
Low:-145.00%
Volatility
-2220.3%
Relatively stable
| Period | Value |
|---|---|
| Q3 2025 | -47.62% |
| Q2 2025 | 40.00% |
| Q1 2025 | -40.00% |
| Q4 2024 | 41.86% |
| Q3 2024 | 10.42% |
| Q2 2024 | 14.29% |
| Q1 2024 | 1.75% |
| Q4 2023 | 12.31% |
| Q3 2023 | 19.75% |
| Q2 2023 | -8.00% |
| Q1 2023 | -13.64% |
| Q4 2022 | -17.86% |
| Q3 2022 | -7.69% |
| Q2 2022 | -30.00% |
| Q1 2022 | 4.76% |
| Q4 2021 | 33.33% |
| Q3 2021 | -28.57% |
| Q2 2021 | -145.00% |
| Q1 2021 | 0.00% |